Objectives-To evaluate gonococcal (GU) and nongonococcal urethritis (NGU), chlamydia antigen, and serostatus for syphilis and human immunodeficiency virus (HIV) among males attending a Malawian STD clinic with complaints of urethral discharge andfor dysuria. To collect demographic and behavioural data and to determine the effectiveness of five treatments for urethritis. Methods-Urethritis was diagnosed using microscopy and culture for Neisseria gonorrhoeae. Sera were screened with rapid plasma reagin (RPR) and if reactive, with microhaemagglutination for Treponema pallidum (MHA-TP). HIV antibodies and chlamydia antigen were detected using enzyme niminoassay. Patients were randomised for treatment, cure was assessed 8-10 days later. Results-At enrolment, GU was diagnosed in 415 (80.3%) and NGU in 59 (11.2%) of 517 males. Chlamydia antigen was found in 26 (5.2%) of 497 specimens tested. Syphilis seropositivity rate (RPR and MHA-TP reactive) was 10-7%. Overall HIV seroprevalence was 44.2%; 71-7% of men with reactive syphilis serology were HIV( +) compared with 40
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The effects of therapy on all urethritis 14-2 patients were further analysed based on laboratory data at follow-up as shown in the second part of 
Discussion
In this study, infection with Neisseria gonorrhoeae was confirmed in 80.3% of all patients presenting with complaints of urethral discharge and/or dysuria, whereas Chlamydia trachomatis (as determined by direct antigen detection using EIA) was not a major pathogen. A similarly low prevalence of chlamydia (34-4%) was found among pregnant women in Blantyre.5 Among patients symptomatic at follow-up visit we also detected few carriers of chlamydia antigen. We did not screen for other organisms associated with NGU such as Ureaplasma urealyticum and Trichomonas vaginalis.
At enrolment, complaints of dysuria and/or urethral discharge among our study participants were highly specific for laboratory confinned urethritis. In this setting, the syndromic approach for management of patients presenting with complaints of dysuria and/or urethral discharge using a simple algorithm requires no laboratory analyses except syphilis screening. Our findings are not applicable for asymptomatic patients who do require laboratory diagnosis for detection. For instance, in a community-based study in Tanzania, asymptomatic infection was found in 90% of men infected with gonorrhoea or chlamydia.7 The importance of using effective therapy was illustrated at follow-up where we documented that 85% of the men who had gonococcal infection reported complete resolution or substantial improvement of symptoms.
Trimethoprim 320 mg/sulphamethoxazole 1600 mg PO for 2 days or amoxicillin 3 gm, probenicid 1 gm, and clavulanate 125 mg PO once were ineffective for treatment of gonococcal urethritis. The 
